The PIGC gene helps cells attach certain proteins to their outer surface, where those proteins support brain, nerve, and body development. This gene plays an important role in making GPI anchors, the tiny links that hold these proteins in place. If the gene does not work properly, fewer proteins reach the cell surface, which can lead to developmental delay, seizures, low muscle tone, and other features of a rare inherited condition.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate activities in the body. Some genes give the directions for producing proteins, which are the parts of cells that do much of the work. Other genes mostly control when certain processes take place, where they take place, and how active they are. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a deeper look at this topic, you can read more in the LearnHub.
Overview
PIGCGene function
What if the gene works
The PIGC gene helps cells make special anchors that attach certain proteins to the cell surface. These surface proteins help with cell communication, immune function, and early development.
Risk
What if the gene does not work
When the PIGC gene does not work properly, cells make fewer GPI anchors, affecting many surface proteins. More severe variants can cause developmental delay, seizures, low muscle tone, and sometimes birth differences, while milder variants may cause fewer features.
Treatment
What does that mean for your treatment
No PIGC-specific treatment or drug selection approach is currently established. The PIGC gene is part of the GPI anchor pathway, which is under study in related inherited conditions, but this has not yet led to a proven therapy targeted to the PIGC gene.
Conditions associated with PIGC
Gene function
What if the gene works
Knowing what the PIGC gene does helps explain how cells keep certain proteins attached to their outer surface. This steady placement matters because many cell surface proteins need to stay in the right spot to do their everyday jobs. In your cells, the PIGC gene supports an early step in making GPI anchors, which are small molecular ties for certain proteins.
The PIGC gene helps start making GPI anchors, which attach certain proteins to the cell surface. It works as part of a larger enzyme group in the endoplasmic reticulum, the cell’s protein-processing area.
One of its main roles is to add an early sugar piece to a fat molecule called phosphatidylinositol. This is one of the first committed steps in GPI anchor biosynthesis, so it helps set the whole process in motion.
By supporting GPI anchor production, the PIGC gene helps certain proteins stay attached to the outer cell membrane. This lets those proteins remain in the right place for routine cell activity.
Many GPI-anchored proteins help cells communicate, interact, and carry out surface tasks. Because of this, PIGC supports normal day-to-day cell function across many tissues.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These differences are common and help create normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many have no noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the PIGC gene can reduce or block a cell-surface anchor tag called GPI, so some proteins do not attach properly to cells. Milder variants may leave some activity. More disruptive variants can stop this process. These PIGC gene variant effects on GPI anchor production change how many proteins reach the cell surface, and in people with two disease-causing variants, lower residual activity is often linked to earlier onset and more marked developmental and seizure features.
How variants are linked to conditions
Pathogenic variants in the PIGC gene are linked to glycosylphosphatidylinositol biosynthesis defect 16, a rare inherited condition, and PIGC gene variants linked to developmental delay and seizures have been described in several affected families. People with this diagnosis often have developmental delay, low muscle tone, seizures, and intellectual disability. Some also have feeding difficulties, brain imaging changes, or raised alkaline phosphatase levels, and the pattern can vary from person to person.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widely found across the general population. Most do not directly affect health and simply reflect natural variation among people. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences play a role. In some situations, though, one well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For PIGC, risk is mainly determined by genetics rather than lifestyle. A child’s chance of having a PIGC-related condition is higher when both parents carry a harmful PIGC change, and this can be more likely in closely related parents. There is not enough evidence to say that diet, exercise, or other everyday factors change this risk.
Inheritance of PIGC variants
For families asking about the inheritance of the PIGC gene variants, the well-established pattern is autosomal recessive. This means a child usually inherits one altered copy of the PIGC gene from each parent. Parents who each carry one variant are often unaffected, and with each pregnancy there is a 25% chance the child will inherit both altered copies, a 50% chance the child will be a carrier, and a 25% chance the child will inherit neither variant. This pattern applies equally to boys and girls.
What does my PIGC result mean for my family?
For families with a disease-causing PIGC result, the pattern is usually recessive, which means parents are often healthy carriers. Brothers and sisters may also have the condition or be carriers, so close relatives may want to learn whether they carry the same gene change, especially when planning a pregnancy. Children of someone with PIGC-related disease will usually be carriers unless the other parent also carries a PIGC change.
Genetic information
Genetic testing
How you find out about variants
Variants in the PIGC gene are usually found through a blood or saliva test that reads the gene’s DNA, often as part of a multigene panel, exome sequencing, or genome sequencing. If you are looking into how to test for PIGC gene variants, the lab compares your DNA with the usual sequence and reports whether a variant was found.
When should I consider getting a genetic test?
Testing for the PIGC gene may be considered when a child has unexplained developmental delay, seizures, low muscle tone, or several birth differences, especially if similar problems run in the family. It can also be useful when both parents are known carriers of a PIGC change or after a pregnancy is affected.
A genetic result is only one part of your health story
A genetic result can provide helpful insight, but how much it explains varies by the condition and the type of variant involved. Many factors, including lifestyle, environment, age, and medical history, affect how the body works over time. For some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas such as medication response, genetic results may help place personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body handles a medicine, so the same treatment may not work the same way for everyone. Some people break down a drug more quickly or more slowly, which can change how much benefit they get or how likely they are to notice side effects. These differences are common and are one reason medication response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics is the area of study that examines how genetic differences affect response to medications. It focuses on links between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body handles it. This information can support better informed, more individualized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the PIGC gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in how medicines are chosen or used. If you have concerns about side effects, new symptoms, or how a treatment may affect you, speak with your doctor or pharmacist.
History
PIGC entered the scientific literature during the broader effort to map the group of genes involved in making glycosylphosphatidylinositol, often shortened to GPI, anchors in cells. Researchers identified the PIGC gene as one member of the PIG gene family while piecing together this pathway in the late 1990s and early 2000s. Building on this early work, scientists uncovered more about the gene through laboratory studies that compared related genes across species. Later, clinical genetics linked rare variants in the PIGC gene to inherited conditions affecting early development and neurologic function. Over time, descriptions became more precise as gene sequencing made it easier to connect specific PIGC variants with a person’s symptoms.